Gou ZC - Search Results

1

Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study.

Ge LP, Liu XY, Xiao Y, Gou ZC, Zhao S, Jiang YZ, Di GH. Ge LP, et al. Among authors: gou zc. Cancer Manag Res. 2018 Oct 9;10:4381-4391. doi: 10.2147/CMAR.S169019. eCollection 2018. Cancer Manag Res. 2018. PMID: 30349371 Free PMC article.

2

Decreased survival in patients with carcinoma of axillary tail versus upper outer quadrant breast cancers: a SEER population-based study.

Gou ZC, Liu XY, Xiao Y, Zhao S, Jiang YZ, Shao ZM. Gou ZC, et al. Cancer Manag Res. 2018 May 14;10:1133-1141. doi: 10.2147/CMAR.S165291. eCollection 2018. Cancer Manag Res. 2018. PMID: 29795985 Free PMC article.

3

SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer.

Liu XY, Jiang W, Ma D, Ge LP, Yang YS, Gou ZC, Xu XE, Shao ZM, Jiang YZ. Liu XY, et al. Among authors: gou zc. Theranostics. 2020 Aug 29;10(24):10940-10956. doi: 10.7150/thno.45207. eCollection 2020. Theranostics. 2020. PMID: 33042263 Free PMC article.

4

The Prognostic Impact of Age at Diagnosis Upon Breast Cancer of Different Immunohistochemical Subtypes: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Analysis.

Cai S, Zuo W, Lu X, Gou Z, Zhou Y, Liu P, Pan Y, Chen S. Cai S, et al. Front Oncol. 2020 Sep 23;10:1729. doi: 10.3389/fonc.2020.01729. eCollection 2020. Front Oncol. 2020. PMID: 33072554 Free PMC article.

5

A novel risk model based on immune response predicts clinical outcomes and characterizes immunophenotypes in triple-negative breast cancer.

Lu X, Gou Z, Yu L, Bu H. Lu X, et al. Am J Cancer Res. 2022 Aug 15;12(8):3913-3931. eCollection 2022. Am J Cancer Res. 2022. PMID: 36119814 Free PMC article.

6

Trends in axillary surgery and clinical outcomes among breast cancer patients with sentinel node metastasis.

Gou Z, Lu X, He M, Yu L. Gou Z, et al. Breast. 2022 Jun;63:9-15. doi: 10.1016/j.breast.2022.02.014. Epub 2022 Mar 1. Breast. 2022. PMID: 35245747 Free PMC article.

7

Prognostic value and tumour microenvironment characteristics of the Glasgow Microenvironment Score in primary triple-negative breast cancer.

Lu X, Wang Y, He M, Gou Z. Lu X, et al. J Clin Pathol. 2024 Jan 18;77(2):128-134. doi: 10.1136/jcp-2022-208601. J Clin Pathol. 2024. PMID: 36600565

8

Is repeat sentinel lymph node biopsy possible for surgical axillary staging among patients with ipsilateral breast tumor recurrence?

Lu X, He M, Yu L, Gou Z. Lu X, et al. Cancer. 2023 May 15;129(10):1492-1501. doi: 10.1002/cncr.34708. Epub 2023 Feb 19. Cancer. 2023. PMID: 36807239 Free article.

9

Gene panel predicts neoadjuvant chemoimmunotherapy response and benefit from immunotherapy in HER2-negative breast cancer.

Lu X, Gou Z, Chen H, Li L, Chen F, Bao C, Bu H. Lu X, et al. J Immunother Cancer. 2024 Aug 12;12(8):e009587. doi: 10.1136/jitc-2024-009587. J Immunother Cancer. 2024. PMID: 39134345 Free PMC article.

10

Effects of postmastectomy radiotherapy on survival in different age groups for patients with T3N0M0 breast cancer.

He MT, Lu XX, Gou ZC. He MT, et al. Among authors: gou zc. Breast. 2021 Dec;60:247-254. doi: 10.1016/j.breast.2021.11.006. Epub 2021 Nov 16. Breast. 2021. PMID: 34808436 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters